Vitamin D Treatment of Diabetic Patients With Foot Ulcers
Primary Purpose
Diabetic Foot Ulcers, Vitamin D Deficiency
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Vitamin D
Placebo
Sponsored by
About this trial
This is an interventional basic science trial for Diabetic Foot Ulcers
Eligibility Criteria
Inclusion Criteria:
- Age > 18 years
- Diagnosed diabetes.
- Foot ulcers more than 6 weeks.
- Informed consent
Exclusion Criteria:
- Pregnancy
- Granulomatous diseases such as tuberculosis, sarcoidosis and silicosis
- Hypercalcemia
- Supplementation of vitamin D > 20 μg a day
- Renal disease
- Liver disease
- Osteomyelitis
- Skin cancer.
- Epilepsy.
- High blod pressure (> 150/100 mmHg).
- Indication for surgical revision.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Vitamin D
Placebo
Arm Description
supplementation with tablet 170 μg Vitamin D each day.
Placebo, tablet with 20 μg Vitamin D each day.
Outcomes
Primary Outcome Measures
Wound healing
Wound healing, measured in square cm
Secondary Outcome Measures
Vitamin D blod level status
Vitamin D blod level status in intervention Group after supplementation.
Full Information
NCT ID
NCT03813927
First Posted
January 9, 2019
Last Updated
January 21, 2019
Sponsor
Zealand University Hospital
1. Study Identification
Unique Protocol Identification Number
NCT03813927
Brief Title
Vitamin D Treatment of Diabetic Patients With Foot Ulcers
Official Title
Systemic Vitamin D Treatment of Diabetic Patients With Foot Ulcers: a Clinical Controlled Investigation of the Effect on Healing
Study Type
Interventional
2. Study Status
Record Verification Date
January 2019
Overall Recruitment Status
Completed
Study Start Date
April 1, 2016 (Actual)
Primary Completion Date
December 31, 2017 (Actual)
Study Completion Date
July 3, 2018 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Zealand University Hospital
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this study, is to determine whether daily supplements of vitamin D improves wound healing in diabetic patients with chronic foot ulcers.
Detailed Description
Project title
"Treatment with oral vitamin D in diabetic patients with chronic foot ulcers on the lower limb; a clinical controlled study of the effect on wound healing".
Abstract
Aims and objectives
The purpose of this study is to determine whether daily supplements of vitamin D improves wound healing in diabetic patients with chronic foot ulcers.
Background
Lifetime risk of developing chronic lower extremity ulcers summarized in type I and type II diabetics is about 25% and the prevalence is approximately 7%. There is often a long term resource consuming disorder where 47% of the diabetic leg and foot ulcers effectively can be treated within 12 months.
In Denmark in 2011 there were more than 300,000 diagnosed type I and type II diabetics, and estimated about 200,000 undiagnosed type II diabetics. Therefore, approximately 35,000 diabetics each year are treated for chronic leg or foot ulcers in the Danish health sector. The treatment of these chronic wounds are associated with significant costs, as well as emotional, physical and financial.
Vitamin D deficiency is a widespread problem, and it is estimated that worldwide there is 1 billion people suffering from vitamin D deficiency. A Danish study from 2012 showed vitamin D deficiency in 52% of adults aged 30 60 years. Vitamin D deficiency is more common in diabetics with chronic foot or leg ulcers, when compared with non diabetics and diabetics without ulcers.
Methods and materials
48 diabetic patients with chronic foot ulcers will be included in the study. The patients will be recruited from the outpatient clinic, department of orthopaedic surgery at Zealand University Hospital, Denmark. The patients will randomly be divided into two groups, respectively treated with vitamin D or placebo.
Expected outcome and perspectives
The investigators expect that this study will show that supplementation with oral vitamin D, will result in a significant effect on wound treatment and healing for a large group of diabetic patients with chronic foot ulcers. This will contribute to a changed procedure in this specific group of patients, leading to measurement of vitamin D status and supplementation with vitamin D if needed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetic Foot Ulcers, Vitamin D Deficiency
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
48 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Vitamin D
Arm Type
Experimental
Arm Description
supplementation with tablet 170 μg Vitamin D each day.
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Placebo, tablet with 20 μg Vitamin D each day.
Intervention Type
Dietary Supplement
Intervention Name(s)
Vitamin D
Intervention Description
Supplementation with tablet 170 μg Vitamin each day.
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
Placebo with tablet 20 μg Vitamin each day.
Primary Outcome Measure Information:
Title
Wound healing
Description
Wound healing, measured in square cm
Time Frame
48 weeks or wound healing.
Secondary Outcome Measure Information:
Title
Vitamin D blod level status
Description
Vitamin D blod level status in intervention Group after supplementation.
Time Frame
48 weeks or wound healing.
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Age > 18 years
Diagnosed diabetes.
Foot ulcers more than 6 weeks.
Informed consent
Exclusion Criteria:
Pregnancy
Granulomatous diseases such as tuberculosis, sarcoidosis and silicosis
Hypercalcemia
Supplementation of vitamin D > 20 μg a day
Renal disease
Liver disease
Osteomyelitis
Skin cancer.
Epilepsy.
High blod pressure (> 150/100 mmHg).
Indication for surgical revision.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Peter Max Halschou-Jensen, MD
Organizational Affiliation
Zeeland University Hospital, Denmark
Official's Role
Study Director
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Vitamin D Treatment of Diabetic Patients With Foot Ulcers
We'll reach out to this number within 24 hrs